CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −856 | 856 | ||
| 2025-10-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +3,386 | 157,458 | ||
| 2025-10-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Restricted Stock Unit 10b5-1 | −3,386 | 3,386 | ||
| 2025-10-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,522 | 70,711 | ||
| 2025-10-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −1,522 | 1,522 | ||
| 2025-10-20 | Sheena Jonathan Director | Option exercise 10b5-1 | +190 | 236,302 | ||
| 2025-10-20 | Sheena Jonathan Director | Option exercise · Restricted Stock Unit 10b5-1 | −190 | 191 | ||
| 2025-10-20 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −10,000 | $190.00 | $1.9M | 5,000 |
| 2025-10-17 | Sheena Jonathan Director | Sale 10b5-1 | −475 | $178.66 | $85K | 28,307 |
| 2025-10-17 | Sheena Jonathan Director | Sale 10b5-1 | −275 | $179.35 | $49K | 28,032 |
| 2025-10-17 | Sheena Jonathan Director | Sale 10b5-1 | −413 | $178.58 | $74K | 28,369 |
| 2025-10-17 | Sheena Jonathan Director | Sale 10b5-1 | −337 | $179.29 | $60K | 28,032 |
| 2025-10-15 | Sheena Jonathan Director | Sale 10b5-1 | −153 | $172.99 | $26K | 239,029 |
| 2025-10-15 | Sheena Jonathan Director | Sale 10b5-1 | −1,506 | $175.11 | $264K | 237,523 |
| 2025-10-15 | Sheena Jonathan Director | Sale 10b5-1 | −988 | $175.90 | $174K | 236,535 |
| 2025-10-15 | Sheena Jonathan Director | Sale 10b5-1 | −423 | $176.63 | $75K | 236,112 |
| 2025-10-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −404 | $158.96 | $64K | 120,155 |
| 2025-10-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,816 | $159.91 | $290K | 118,339 |
| 2025-10-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −780 | $160.70 | $125K | 117,559 |
| 2025-10-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −634 | $158.84 | $101K | 167,521 |
Page 37 of 39 · 767 trades